Accepted Insurance Plans
We accept most managed care plans. Please call our office if you have a question about your plan well in advance of your appointment or look at our current list of accepted plans below.
We accept Medicare BUT NOT MEDICAID
Medicare Part D Information
Loudoun Rheumatology Center is pleased to accept the following
health insurance plans:
If you do not see your insurance provider on this list please
call our offices at (703) 723-3398 for further information. We
may be able to obtain or already have obtained provider status
and they do not yet appear on this list. As a courtesy to all our
patients, we are willing to work with all insurance providers with
out of network benefits.
- Aetna (PPO/HMO/EPO/POS)
- Anthem Blue Cross & Blue Shield PPO
- Alliance PPO
- CIGNA (PPO/EPO/POS)
- MAMSI (Currently not accepting new patients)
- MDIPA (Currently not accepting new patients)
- Optimum Choice HMO (Currently not accepting new patients)
- Tricare Standard/HealthNet
- United Healthcare
||Loudoun Rheumatology Center is proud to announce we are now participating in the CORRONA Data Collection Program
(New England Institutional Review Board NEIRB Number: 02-021)
The Consortium of Rheumatology Researchers of North America, Inc. (CORRONA) Data Collection Program is designed to gather health information about a very large group of patients with rheumatic disease. This will include systematically collecting and documenting use, patterns, effectiveness, and safety of medications such as: Disease Modifying Anti-Rheumatic Drugs (DMARD’s), Nonsteroidal Anti-Inflammatory Drugs (NSAID), biologics, and any other treatments currently used in the management of Rheumatoid Arthritis (RA) and Psoriatic Arthritis. It is anticipated that the study data may help improve the quality of information upon which clinical decisions are based.
CORRONA launched the Data Collection Program in an effort to create an information-gathering network for patients with rheumatic diseases in North America. This is not a treatment study, it is an observational study.
Approximately 100,000 patients from as many as 90 sites across the United States are expected to participate.
Patients currently enrolled in database: 14,000
Enrollment period: Ongoing, no determined end at this time
Duration of follow-up: Never ending; RA patients receive a follow-up questionnaire no more than once every three months, and PsA patients no more than once very 6 months.
- Must have documented diagnosis of Rheumatoid Arthritis or Psoriatic Arthritis.
- Must be at least 18 years of age
- Patients excluded from the study include those excluded based on diagnosis (or age) alone
The safety of study participants is our top priority. The trial is approved and periodically reviewed by an Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration. Before enrolling in a clinical trial, the investigator will explain the purpose of the trial, its expected benefits, any possible risks or side effects, and what your role will be.
This is the time to ask questions! If you want to join the trial, you must sign the informed consent documents. You can leave a clinical trial at any time without penalty. We have started enrolling patients, please contact our office staff if you are interested in participating or would like more information.
Jennifer Odutola, MD, MSc